"The Methods in Bioengineering Series was conceived to aid investigators at all levels in understanding and implementing cutting-edge techniques in use today within the most dynamic and impactful areas of bioengineering. Our goal with this Series is to provide a means for innovations and methods to be presented in a thoughtful, detailed fashion for use and appreciation by both novice and experienced hand in industry and academia.

Although, cost-saving efforts in journal publishing in recent years have resulted in Methods sections becoming more limited, this Series offers innovative researchers a means for bringing their work to full blossom, while bringing readers a continual potpourri of the latest techniques of emerging applications that inform, teach, and electrify".

- Martin L. Yarmush and Robert S. Langer - April 2009

Martin L. Yarmush is an internationally recognized bioengineer and biophysical chemist whose laboratory has been a leader in the fields of tissue engineering and regenerative medicine. Dr. Yarmush is the Paul and Mary Monroe Professor of Science and Engineering and Distinguished Professor of Biomedical Engineering at Rutgers University, and the Director of the Center for Engineering in Medicine at the Massachusetts General Hospital.

Over the last 25 years, Dr. Yarmush has published more than 400 journal articles, has mentored over 120 postdoctoral fellows and graduate students, and has co-authored more than 30 patents and patent applications. A frequent invited speaker at major conferences and symposia, and winner of over 30 local and national awards, Dr. Yarmush is known as one of the leading investigators in the area of multiscale bioengineering through seminal contributions to the fields of tissue engineering and regenerative medicine, BioMEMS, applied immunology, metabolic engineering, and genomics and proteomics technologies.

Dr. Yarmush received his Bachelor's Degree from Yeshiva University, his MD degree from Yale University, and completed PhD work at The Rockefeller University (physical biochemistry) and MIT (Chemical Engineering).

Robert S. Langer is an internationally recognized chemical engineer and polymer chemist whose laboratory has been a world leader in the development of polymers and polymer systems for drug delivery. Dr. Langer is Institute Professor at the Massachusetts Institute of Technology with appointments in Chemical Engineering and the Harvard-MIT Division of Health Science and Technology.

Dr. Langer has written over 1,000 journal articles, and has more than 625 issued or pending patents worldwide. Dr. Langer has received over 100 major awards, and has been elected to all three United States National Academies. His research covers a wide range of topics from basic studies investigating the mechanism of release of molecules from polymeric delivery systems (with concomitant microstructural analysis and mathematical modeling), to studying applications of these systems to anti-cancer drugs, gene therapy agents, and vaccines.

Dr. Langer received his Bachelor’s Degree from Cornell University in 1970 and his Sc.D. from the Massachusetts Institute of Technology in 1974, both in Chemical Engineering.